Bristol-myers Squibb Compnay

Rongti Li

Michael S Bowsher

Paul Michael Scola

B Narasimhulu Naidu

Manoj Patel

Michael A Walker

Kevin M Peese

Ramkumar Rajamani

Timothy P Connolly

Margaret E Sorenson

Barry L Johnson

Chen Li

Sheldon Hiebert

Yasutsuga Ueda

The disclosure generally relates to the novel compounds of formula I, including their salts, which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV. 

HIV integrase inhibitors

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C virus inhibitors

Growing community of inventors

Port Lavaca, TX, United States of America

Rongti Li